• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过低顺式三重转染生产高产量和高质量的重组腺相关病毒。

Producing high-quantity and high-quality recombinant adeno-associated virus by low-cis triple transfection.

作者信息

Liu Hao, Zhang Yue, Yip Mitchell, Ren Lingzhi, Liang Jialing, Chen Xiupeng, Liu Nan, Du Ailing, Wang Jiaming, Chang Hao, Oh Hyejin, Zhou Chen, Xing Ruxiao, Xu Mengyao, Guo Peiyi, Gessler Dominic, Xie Jun, Tai Phillip W L, Gao Guangping, Wang Dan

机构信息

Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.

Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.

出版信息

Mol Ther Methods Clin Dev. 2024 Mar 12;32(2):101230. doi: 10.1016/j.omtm.2024.101230. eCollection 2024 Jun 13.

DOI:10.1016/j.omtm.2024.101230
PMID:38558570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10979107/
Abstract

Recombinant adeno-associated virus (rAAV)-based gene therapy is entering clinical and commercial stages at an unprecedented pace. Triple transfection of HEK293 cells is currently the most widely used platform for rAAV manufacturing. Here, we develop low-cis triple transfection that decreases transgene plasmid use by 10- to 100-fold and overcomes several major limitations associated with standard triple transfection. This new method improves packaging of yield-inhibiting transgenes by up to 10-fold, and generates rAAV batches with reduced plasmid backbone contamination that otherwise cannot be eliminated in downstream processing. When tested in mice and compared with rAAV produced by standard triple transfection, low-cis rAAV shows comparable or superior potency and results in diminished plasmid backbone DNA and RNA persistence in tissue. Mechanistically, low-cis triple transfection relies on the extensive replication of transgene cassette (i.e., inverted terminal repeat-flanked vector DNA) in HEK293 cells during production phase. This cost-effective method can be easily implemented and is widely applicable to producing rAAV of high quantity, purity, and potency.

摘要

基于重组腺相关病毒(rAAV)的基因疗法正以前所未有的速度进入临床和商业阶段。HEK293细胞的三重转染是目前rAAV生产中使用最广泛的平台。在此,我们开发了低顺式三重转染方法,该方法可将转基因质粒的使用量减少10至100倍,并克服了与标准三重转染相关的几个主要限制。这种新方法将抑制产量的转基因包装效率提高了多达10倍,并产生了质粒骨架污染减少的rAAV批次,否则在下游加工过程中无法消除这些污染。在小鼠中进行测试并与标准三重转染产生的rAAV相比时,低顺式rAAV显示出相当或更高的效力,并减少了组织中质粒骨架DNA和RNA的残留。从机制上讲,低顺式三重转染依赖于生产阶段HEK293细胞中转基因盒(即反向末端重复序列侧翼的载体DNA)的大量复制。这种经济高效的方法易于实施,广泛适用于生产高质量、高纯度和高效力的rAAV。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/9d599db13ab9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/eb1baa4c4a49/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/cd97bb68c8bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/2f62654c169a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/6afb9470c005/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/368e7e9b7727/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/9d599db13ab9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/eb1baa4c4a49/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/cd97bb68c8bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/2f62654c169a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/6afb9470c005/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/368e7e9b7727/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/10979107/9d599db13ab9/gr5.jpg

相似文献

1
Producing high-quantity and high-quality recombinant adeno-associated virus by low-cis triple transfection.通过低顺式三重转染生产高产量和高质量的重组腺相关病毒。
Mol Ther Methods Clin Dev. 2024 Mar 12;32(2):101230. doi: 10.1016/j.omtm.2024.101230. eCollection 2024 Jun 13.
2
A PCR-amplified transgene fragment flanked by a single copy of a truncated inverted terminal repeat for recombinant adeno-associated virus production prevents unnecessary plasmid DNA packaging.为了生产重组腺相关病毒,一个 PCR 扩增的转基因片段被一个截短的反向末端重复序列的单拷贝侧翼序列所包围,可防止不必要的质粒 DNA 包装。
Gene Ther. 2022 Aug;29(7-8):449-457. doi: 10.1038/s41434-021-00299-x. Epub 2021 Oct 11.
3
Preventing packaging of translatable P5-associated DNA contaminants in recombinant AAV vector preps.防止可翻译的P5相关DNA污染物包装到重组腺相关病毒(AAV)载体制剂中。
Mol Ther Methods Clin Dev. 2022 Jan 19;24:280-291. doi: 10.1016/j.omtm.2022.01.008. eCollection 2022 Mar 10.
4
Production of an Oncolytic Adeno-Associated Virus Containing the Pro-Apoptotic TRAIL Gene Can Be Improved by shRNA Interference.通过shRNA干扰可改善携带促凋亡TRAIL基因的溶瘤腺相关病毒的产生。
Int J Mol Sci. 2025 Jan 10;26(2):567. doi: 10.3390/ijms26020567.
5
Improved productivity of recombinant adeno-associated virus (rAAV) via triple transfection of HEK293 cells using perfusion cultivation.通过使用灌注培养对HEK293细胞进行三重转染提高重组腺相关病毒(rAAV)的产量
Bioprocess Biosyst Eng. 2025 Apr 26. doi: 10.1007/s00449-025-03167-9.
6
Development of an HEK293 Suspension Cell Culture Medium, Transient Transfection Optimization Workflow, and Analytics for Batch rAAV Manufacturing.用于批量重组腺相关病毒(rAAV)生产的HEK293悬浮细胞培养基的开发、瞬时转染优化流程及分析方法
Biotechnol Bioeng. 2025 Apr 8. doi: 10.1002/bit.28980.
7
Mechanistic model for production of recombinant adeno-associated virus via triple transfection of HEK293 cells.通过对HEK293细胞进行三重转染生产重组腺相关病毒的机制模型。
Mol Ther Methods Clin Dev. 2021 Apr 16;21:642-655. doi: 10.1016/j.omtm.2021.04.006. eCollection 2021 Jun 11.
8
Self-amplification system for recombinant adeno-associated virus production.用于重组腺相关病毒生产的自我扩增系统。
Biochem Biophys Res Commun. 2000 Sep 24;276(2):559-63. doi: 10.1006/bbrc.2000.3521.
9
Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.使用包装细胞系和杂交重组腺病毒生产重组腺相关病毒载体。
Gene Ther. 1999 Feb;6(2):293-9. doi: 10.1038/sj.gt.3300807.
10
Production of Recombinant Adeno-Associated Virus Through High-Cell-Density Transfection of HEK293 Cells Based on Fed-Perfusion Culture.基于补料灌注培养通过HEK293细胞的高密度转染生产重组腺相关病毒
Hum Gene Ther. 2025 Feb;36(3-4):116-127. doi: 10.1089/hum.2024.160. Epub 2025 Jan 6.

引用本文的文献

1
Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectors.自我沉默腺病毒可实现重组腺相关病毒载体的精确感染滴定。
Mol Ther Methods Clin Dev. 2025 May 14;33(2):101492. doi: 10.1016/j.omtm.2025.101492. eCollection 2025 Jun 12.
2
AAVone: A cost-effective, single-plasmid solution for efficient AAV production with reduced DNA impurities.AAVone:一种经济高效的单质粒解决方案,用于高效生产腺相关病毒(AAV),并减少DNA杂质。
Mol Ther Nucleic Acids. 2025 May 14;36(2):102563. doi: 10.1016/j.omtn.2025.102563. eCollection 2025 Jun 10.
3
Tracking Particle-Encapsulated DNA Across the Anion-Exchange Chromatography Fractions of Recombinant Adeno-Associated Virus Using Droplet Digital PCR and High-Throughput Sequencing.

本文引用的文献

1
Significant Differences in Capsid Properties and Potency Between Adeno-Associated Virus Vectors Produced in Sf9 and HEK293 Cells.昆虫细胞和人胚肾细胞中生产的腺相关病毒载体在衣壳特性和效力方面存在显著差异。
Hum Gene Ther. 2023 Oct;34(19-20):1003-1021. doi: 10.1089/hum.2022.116. Epub 2023 Oct 4.
2
Design space determination to optimize DNA complexation and full capsid formation in transient rAAV manufacturing.设计空间确定以优化瞬时 rAAV 生产中的 DNA 复合和完整衣壳形成。
Biotechnol Bioeng. 2023 Nov;120(11):3148-3162. doi: 10.1002/bit.28508. Epub 2023 Jul 21.
3
A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes.
使用液滴数字PCR和高通量测序技术追踪重组腺相关病毒阴离子交换色谱级分中的颗粒包裹DNA
Biotechnol J. 2025 Jun;20(6):e70031. doi: 10.1002/biot.70031.
4
Advancing AAV technology: From capsid design to scalable manufacturing.推进腺相关病毒技术:从衣壳设计到可扩展制造。
Mol Ther Methods Clin Dev. 2025 May 7;33(2):101477. doi: 10.1016/j.omtm.2025.101477. eCollection 2025 Jun 12.
5
High-purity AAV vector production utilizing recombination-dependent minicircle formation and genetic coupling.利用依赖重组的微环形成和基因偶联生产高纯度腺相关病毒(AAV)载体
EMBO Mol Med. 2025 May 16. doi: 10.1038/s44321-025-00248-w.
6
Development of an HEK293 Suspension Cell Culture Medium, Transient Transfection Optimization Workflow, and Analytics for Batch rAAV Manufacturing.用于批量重组腺相关病毒(rAAV)生产的HEK293悬浮细胞培养基的开发、瞬时转染优化流程及分析方法
Biotechnol Bioeng. 2025 Apr 8. doi: 10.1002/bit.28980.
一种新型双质粒平台可实现可扩展的转染,在多种腺相关病毒(AAV)血清型和基因组中提高产量和包装效率。
Mol Ther Methods Clin Dev. 2023 May 8;29:426-436. doi: 10.1016/j.omtm.2023.05.004. eCollection 2023 Jun 8.
4
Clinical and genetic characteristics of children with COX20-associated mitochondrial disorder: case report and literature review.COX20 相关线粒体疾病患儿的临床和遗传学特征:病例报告及文献复习。
BMC Med Genomics. 2023 Apr 24;16(1):86. doi: 10.1186/s12920-023-01513-y.
5
AAV vectors: The Rubik's cube of human gene therapy.AAV 载体:人类基因治疗的魔方。
Mol Ther. 2022 Dec 7;30(12):3515-3541. doi: 10.1016/j.ymthe.2022.09.015. Epub 2022 Oct 5.
6
AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice.腺相关病毒(AAV)递送的抑制性 tRNA 可克服小鼠中的无义突变。
Nature. 2022 Apr;604(7905):343-348. doi: 10.1038/s41586-022-04533-3. Epub 2022 Mar 23.
7
Human and Insect Cell-Produced Recombinant Adeno-Associated Viruses Show Differences in Genome Heterogeneity.人源和昆虫细胞生产的重组腺相关病毒在基因组异质性方面存在差异。
Hum Gene Ther. 2022 Apr;33(7-8):371-388. doi: 10.1089/hum.2022.050.
8
Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination.自衰减腺病毒可实现高产量生产重组腺相关病毒,且无污染。
Nat Commun. 2022 Mar 7;13(1):1182. doi: 10.1038/s41467-022-28738-2.
9
Strategies to package recombinant Adeno-Associated Virus expressing the N-terminal gasdermin domain for tumor treatment.用于肿瘤治疗的表达 N 端 Gasdermin 结构域的重组腺相关病毒的包装策略。
Nat Commun. 2021 Dec 9;12(1):7155. doi: 10.1038/s41467-021-27407-0.
10
Durable cell and gene therapy potential patient and financial impact: US projections of product approvals, patients treated, and product revenues.持久细胞和基因治疗的潜在患者和财务影响:美国对产品批准、治疗患者和产品收入的预测。
Drug Discov Today. 2022 Jan;27(1):17-30. doi: 10.1016/j.drudis.2021.09.001. Epub 2021 Sep 17.